Pacemakers and Implantable Defibrillators
Methodology & AI Transparency ⓘ
Pacemakers and Implantable Defibrillators Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: An arrhythmia is any disorder of your heart rate or rhythm.
- 2 Real-world patient consensus: Clinical coding for Pacemakers and Implantable Defibrillators uses ICD-10 I42.9 across Heart & Vascular specialty care.
- 3 Typical cash cost range: Workup highlights for Pacemakers and Implantable Defibrillators (I42.9): ambulatory rhythm monitoring [Pacemakers and Implantable Defibrillators I42.9].
- 4 Top reported side effects / signs: Follow-up benchmark in Pacemakers and Implantable Defibrillators: maintaining Left Ventricular Ejection in Pacemakers and Implantable Defibrillators (I42.9: Fraction (LVEF)) within 55% – 70% (I42.9).
Ask our AI Specialists anything about Pacemakers and Implantable Defibrillators
What Is Pacemakers and Implantable Defibrillators?
An arrhythmia is any disorder of your heart rate or rhythm. It means that your heart beats too quickly, too slowly, or with an irregular pattern. Most arrhythmias result from problems in the electrical system of the heart. If your arrhythmia is serious, you may need a cardiac pacemaker or an implantable cardioverter defibrillator (ICD). They are devices that are implanted in your chest or abdomen. A pacemaker helps control abnormal heart rhythms. It uses electrical pulses to prompt the heart to beat at a normal rate. It can speed up a slow heart rhythm, control a fast heart rhythm, and coordinate the chambers of the heart. An ICD monitors heart rhythms.
Pathophysiology, Underlying Causes & Clinical Presentation
Underlying Pacemakers and Implantable Defibrillators (code I42.9) is coronary microvascular remodeling [Pacemakers and Implantable Defibrillators I42.9], Cross-referenced with NIH MeSH (Defibrillators, Implantable, Pacemaker, Artificial), which Heart & Cardiovascular Disease clinicians address while surveilling Left Ventricular Ejection in Pacemakers and Implantable Defibrillators (I42.9: Fraction (LVEF)) (55% – 70% (I42.9)).
Common Symptoms & Clinical Signs
- • Presentation of Pacemakers and Implantable Defibrillators (I42.9): exertional chest pressure in Pacemakers and Implantable Defibrillators (I42.9: or retrosternal tightness)
- • Secondary Pacemakers and Implantable Defibrillators clinical sign: shortness of breath in Pacemakers and Implantable Defibrillators (I42.9: when climbing stairs)
- • Symptom flares in Pacemakers and Implantable Defibrillators correlating with Left Ventricular Ejection in Pacemakers and Implantable Defibrillators (I42.9: Fraction (LVEF)) deviation outside 55% – 70% (I42.9)
- • Functional heart & vascular impact requiring ambulatory rhythm monitoring [Pacemakers and Implantable Defibrillators I42.9] evaluation (I42.9)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Pacemakers and Implantable Defibrillators Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | I42.9 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Heart & Cardiovascular Disease | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Left Ventricular Ejection in Pacemakers and Implantable Defibrillators (I42.9: Fraction (LVEF)) | 55% – 70% (I42.9) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: NT-proBNP [Pacemakers and Implantable Defibrillators I42.9] | < 100 pg/mL (I42.9) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: High-Sensitivity Troponin I [Pacemakers and Implantable Defibrillators I42.9] | < 14 ng/L (I42.9) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Pacemakers and Implantable Defibrillators
Treatment selection for Pacemakers and Implantable Defibrillators depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Pacemakers and Implantable Defibrillators)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Racial differences in incident irregular heartbeat (AFib) among hypertensive Incident AF is substantially less common among black than nonblack hypertensive patients. American journal of hypertension • 2014-07-15 • Randomized Controlled Trial | Multi-cohort | 82/100 | PMID 24552888 ↗ |
Pacemakers and Implantable Defibrillators Patient Community & “People Like Me” Threads
Filter Pacemakers and Implantable Defibrillators community threads and patient logs by age, biological sex, dosage, and treatment duration.